SAN Riversp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-08-22
Share capital
10 000,00 PLN
Registered address
ul. Jasna 12, 38-500 Trepcza, Poland

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 84 days for 2021).

  • 202517/08/2026
  • 202408/07/2025
  • 202319/07/2024
  • 202228/06/2023
  • 202107/10/2022
  • 202010/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 50.42kMedianUSD 55.35kAverageUSD 2.71m
Net profit
This companyUSD -34.98kMedianUSD -1.27kAverageUSD -92.09k
Operating costs
This companyUSD 85.02kMedianUSD 66.19kAverageUSD 2.67m
Assets
This companyUSD 60.38kMedianUSD 133.95kAverageUSD 3.03m

Authorized Representatives

Lucjan Adam Witkowski – President of the Management Board

Manner of representation

Each member of the management board independently or a commercial proxy is authorized to submit declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Lucjan Adam Witkowskiage 49
9$2,431.1290%
Marek Antoni Witkowskiage 76
1$270.1210%

Lucjan Adam Witkowski and Marek Antoni Witkowski hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-10-03.

  • mBank
    55 1140 2004 0000 3112 0974 6464
  • mBank
    14 1140 2004 0000 3702 7925 3262

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

European Funds

ProjectEU co-financing
Development of an innovative product: a sterile swab for collecting samples from the upper respiratory tract of horses.
$75,278

Competitors

Name
Xenstatssp. z o.o.
Pominnosp. z o.o.
Luna Laboratorysp. z o.o.
GenomtecS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Receptonsp. z o.o.
Biostat Research And Developmentsp. z o.o.
Zawamedsp. z o.o.
Stenocoatsp. z o.o.
Immbionicsp. z o.o.

FAQ

Last updated: 2026-08-17